Related Experiment Video

Updated: Aug 17, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches

John T Parissis1, Katerina Fountoulaki, Ioannis Paraskevaidis

  • 1Attikon University Hospital Heart Failure Clinic, Aftocratoros Irakliou 17, 15122, Maroussi, Athens, Greece. jparissis@yahoo.com

Expert Opinion on Investigational Drugs
|June 2, 2005
PubMed

Insights

Depression is common in chronic heart failure (CHF) patients, increasing hospital readmissions and mortality. Treating this comorbidity may improve outcomes and survival in CHF patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Immunology

Background:

  • Depression is highly prevalent in chronic heart failure (CHF) patients, significantly increasing mortality and hospital readmissions.
  • Shared pathophysiological mechanisms link CHF and depression, including HPA axis dysfunction, sympathoadrenal hyperactivity, reduced heart-rate variability, and elevated pro-inflammatory cytokines.

Purpose of the Study:

  • To review the interplay between depression and CHF.
  • To explore therapeutic targets for managing depression in CHF patients.

Main Methods:

  • Review of recent investigational observations.
  • Analysis of antidepressant effects on immune functions.
  • Assessment of anticytokine agents' effects on depressive symptoms in CHF.

Main Results:

  • Antidepressants, particularly selective serotonin re-uptake inhibitors (SSRIs), may improve survival post-myocardial infarction in depressed patients.
  • Targeting shared pathophysiological pathways offers potential therapeutic strategies.

Conclusions:

  • Diagnosis and treatment of depression in CHF patients can positively impact functional capacity and prognosis.
  • Further research into pharmacological interventions targeting immune pathways is warranted for CHF management.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...